The CYP2C19*1/*2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers

Background. The CYP2C19*2 allele may be associated with a reduced antiplatelet effect for clopidogrel. Here, we assessed whether CYP2C19*2 alleles correlate with clopidogrel responsiveness following the administration of clopidogrel in healthy Malaysian volunteers. Methods. Ninety volunteers were ge...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanti Nasyuhana Sani, Lim Sheau Chin, Lim Luen Hui, Nur Elyana Yazmin Mohd Redhuan Shah Edwin, Goh Teck Hwa, Victor L. Serebruany, Yuen Kah Hay
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2013/128795
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553021570023424
author Yanti Nasyuhana Sani
Lim Sheau Chin
Lim Luen Hui
Nur Elyana Yazmin Mohd Redhuan Shah Edwin
Goh Teck Hwa
Victor L. Serebruany
Yuen Kah Hay
author_facet Yanti Nasyuhana Sani
Lim Sheau Chin
Lim Luen Hui
Nur Elyana Yazmin Mohd Redhuan Shah Edwin
Goh Teck Hwa
Victor L. Serebruany
Yuen Kah Hay
author_sort Yanti Nasyuhana Sani
collection DOAJ
description Background. The CYP2C19*2 allele may be associated with a reduced antiplatelet effect for clopidogrel. Here, we assessed whether CYP2C19*2 alleles correlate with clopidogrel responsiveness following the administration of clopidogrel in healthy Malaysian volunteers. Methods. Ninety volunteers were genotyped for CYP2C19*2 and CYP2C19*3 alleles. Forty-five of 90 volunteers were included in the clopidogrel response studies and triaged into three genotypes, namely, CYP2C19*1/*1 (n=17), CYP2C19*1/*2 (n=21), and CYP2C19*2/*2 (n=7). All subjects received 300 mg of clopidogrel, and platelet reactivity was assessed after a four-hour loading utilizing the VerifyNow-P2Y12 assay. Platelet activity was reported using P2Y12 reaction units (PRUs), and nonresponder status was prespecified at PRU ≥ 230. Results. Following clopidogrel intake, CYP2C19*2/*2 carriers had a significantly higher mean PRU compared to the CYP2C19*1/*2 and CYP2C19*1/*1 (291.0 ± 62.1 versus 232.5 ± 81.4 versus 147.4 ± 87.2 PRU, P<0.001) carriers. Almost half of the participants (46.7%) were found to be nonresponders (3 were CYP2C19*1/*1, 11 were CYP2C19*1/*2, and 7 were CYP2C19*2/*2). Conclusion. In healthy Malaysian volunteers, CYP2C19*2 allele was associated with a decrease in platelet responsiveness to clopidogrel. However, clopidogrel nonresponders can be found not only in the carriers of CYP2C19*2/*2, but also in the carriers of CYP2C19*1/*2 and CYP2C19*1/*1. The present paper demonstrated that genotype information does not correlate with clopidogrel response, and genotyping may represent a less robust approach compared to platelet activity testing in guiding clopidogrel therapy.
format Article
id doaj-art-e7822358522b45819040d1f196eda22d
institution Kabale University
issn 2090-8016
2090-0597
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-e7822358522b45819040d1f196eda22d2025-02-03T05:57:11ZengWileyCardiology Research and Practice2090-80162090-05972013-01-01201310.1155/2013/128795128795The CYP2C19*1/*2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian VolunteersYanti Nasyuhana Sani0Lim Sheau Chin1Lim Luen Hui2Nur Elyana Yazmin Mohd Redhuan Shah Edwin3Goh Teck Hwa4Victor L. Serebruany5Yuen Kah Hay6School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, MalaysiaSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, MalaysiaSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, MalaysiaSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, MalaysiaLoh Guan Lye Specialists Centre, Heart Unit, 10400 Penang, MalaysiaJohns Hopkins University, Johns Hopkins Medicine, Towson, Baltimore, MD 21204, USASchool of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, MalaysiaBackground. The CYP2C19*2 allele may be associated with a reduced antiplatelet effect for clopidogrel. Here, we assessed whether CYP2C19*2 alleles correlate with clopidogrel responsiveness following the administration of clopidogrel in healthy Malaysian volunteers. Methods. Ninety volunteers were genotyped for CYP2C19*2 and CYP2C19*3 alleles. Forty-five of 90 volunteers were included in the clopidogrel response studies and triaged into three genotypes, namely, CYP2C19*1/*1 (n=17), CYP2C19*1/*2 (n=21), and CYP2C19*2/*2 (n=7). All subjects received 300 mg of clopidogrel, and platelet reactivity was assessed after a four-hour loading utilizing the VerifyNow-P2Y12 assay. Platelet activity was reported using P2Y12 reaction units (PRUs), and nonresponder status was prespecified at PRU ≥ 230. Results. Following clopidogrel intake, CYP2C19*2/*2 carriers had a significantly higher mean PRU compared to the CYP2C19*1/*2 and CYP2C19*1/*1 (291.0 ± 62.1 versus 232.5 ± 81.4 versus 147.4 ± 87.2 PRU, P<0.001) carriers. Almost half of the participants (46.7%) were found to be nonresponders (3 were CYP2C19*1/*1, 11 were CYP2C19*1/*2, and 7 were CYP2C19*2/*2). Conclusion. In healthy Malaysian volunteers, CYP2C19*2 allele was associated with a decrease in platelet responsiveness to clopidogrel. However, clopidogrel nonresponders can be found not only in the carriers of CYP2C19*2/*2, but also in the carriers of CYP2C19*1/*2 and CYP2C19*1/*1. The present paper demonstrated that genotype information does not correlate with clopidogrel response, and genotyping may represent a less robust approach compared to platelet activity testing in guiding clopidogrel therapy.http://dx.doi.org/10.1155/2013/128795
spellingShingle Yanti Nasyuhana Sani
Lim Sheau Chin
Lim Luen Hui
Nur Elyana Yazmin Mohd Redhuan Shah Edwin
Goh Teck Hwa
Victor L. Serebruany
Yuen Kah Hay
The CYP2C19*1/*2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers
Cardiology Research and Practice
title The CYP2C19*1/*2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers
title_full The CYP2C19*1/*2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers
title_fullStr The CYP2C19*1/*2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers
title_full_unstemmed The CYP2C19*1/*2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers
title_short The CYP2C19*1/*2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers
title_sort cyp2c19 1 2 genotype does not adequately predict clopidogrel response in healthy malaysian volunteers
url http://dx.doi.org/10.1155/2013/128795
work_keys_str_mv AT yantinasyuhanasani thecyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers
AT limsheauchin thecyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers
AT limluenhui thecyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers
AT nurelyanayazminmohdredhuanshahedwin thecyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers
AT gohteckhwa thecyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers
AT victorlserebruany thecyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers
AT yuenkahhay thecyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers
AT yantinasyuhanasani cyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers
AT limsheauchin cyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers
AT limluenhui cyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers
AT nurelyanayazminmohdredhuanshahedwin cyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers
AT gohteckhwa cyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers
AT victorlserebruany cyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers
AT yuenkahhay cyp2c1912genotypedoesnotadequatelypredictclopidogrelresponseinhealthymalaysianvolunteers